Ozempic (semaglutide) is a GLP-1 receptor agonist approved for adults with type 2 diabetes to help manage blood sugar, to lower the risk of heart attack and stroke in those with heart disease, and to reduce the risk of kidney failure and worsening kidney disease in those with chronic kidney disease
Not all colors are normal
Evidence-Based Strategies to Reduce Post-Meal Nausea The most effective nausea-prevention strategy is eating smaller, more frequent meals throughout the day
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes
The effect of nanomicelle curcumin supplementation and Nigella sativa oil on the expression level of miRNA-21, miRNA-422a, and miRNA-503 gene in postmenopausal women with low bone mass density: A randomized, triple-blind, placebo-controlled clinical trial with factorial design
Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions